Hartman Robert J, Helfand Brian T, Dalton Daniel P
Department of Urology, Northwestern University Feinberg School of Medicine, Chicago, Illinois 60611-3008, USA.
Can J Urol. 2011 Feb;18(1):5564-7.
Osseous metaplasia is a rare histologic feature not often associated with renal cell carcinoma; there are only 14 reported cases and just four associated with the clear cell variant. We report the case of a 48-year-old female who presented with diffuse abdominal pain.
We reviewed the case of woman who underwent a robotic assisted partial nephrectomy for an enhancing renal mass. Histologic analyses and immunostains were reviewed by multiple pathologists.
CT imaging revealed a 1.8 cm irregular enhancing exophytic mass with calcifications. The patient subsequently underwent robotic assisted laparoscopic partial nephrectomy. The final pathologic diagnosis was clear cell carcinoma with metaplastic bone formation.
While the prognostic significance of bone metaplasia occurrence in renal cell carcinoma is controversial, such that can safely be managed with partial nephrectomy.
骨化生是一种罕见的组织学特征,不常与肾细胞癌相关;仅有14例报告病例,其中仅4例与透明细胞变体相关。我们报告一例48岁女性,表现为弥漫性腹痛。
我们回顾了一名因肾脏强化肿块接受机器人辅助部分肾切除术的女性病例。多位病理学家对组织学分析和免疫染色进行了复查。
CT成像显示一个1.8厘米不规则强化的外生性肿块伴有钙化。患者随后接受了机器人辅助腹腔镜部分肾切除术。最终病理诊断为伴有化生骨形成的透明细胞癌。
虽然肾细胞癌中发生骨化生的预后意义存在争议,但可以通过部分肾切除术安全地进行处理。